Revenue
2018
2019
2020
2021
2022
2023
2024
2025
Elanco Animal Health Inc (ELAN)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.71B | $4.44B | $4.42B | $4.41B | $4.76B | $3.27B | $3.07B | $3.07B | $2.89B | $2.91B |
| Gross profit | $2.59B | $2.44B | $2.49B | — | — | — | — | — | — | — |
| Research & development | $368.0M | $344.0M | $327.0M | $321.0M | $369.0M | $329.0M | $270.0M | $246.6M | $251.7M | $265.8M |
| Net income | −$232.0M | $338.0M | −$1.23B | −$78.0M | −$483.0M | −$574.0M | $68.0M | $86.5M | −$310.7M | −$47.9M |
| Basic EPSper diluted share | -$0.47 | $0.68 | -$2.50 | -$0.16 | -$0.99 | -$1.30 | $0.18 | $0.28 | -$1.06 | -$0.16 |
| Diluted EPSper diluted share | -$0.47 | $0.68 | -$2.50 | -$0.16 | -$0.99 | -$1.30 | $0.18 | $0.28 | -$1.06 | -$0.16 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 15, 2026Form 4 | Modi Rajeev A.SEE REMARKS | BuyCommon Stock | 4.9K | $20.35 | $99.9K | 160.8K |
| May 15, 2026Form 4 | Simmons Jeffrey NPRESIDENT, CEO AND DIRECTOR | BuyCommon Stock · indirect | 5.0K | $20.09 | $99.9K | 172.0K |
| Dec 12, 2025Form 4 | Kurzius Lawrence ErikDirector | BuyCommon Stock | 10.0K | $21.30 | $213.0K | 131.8K |
| Dec 11, 2025Form 4 | Modi Rajeev A.SEE REMARKS | BuyCommon Stock | 4.5K | $21.33 | $96.0K | 123.1K |
| Dec 11, 2025Form 4 | VanHimbergen Robert MEVP and CFO | BuyCommon Stock | 7.0K | $21.64 | $150.4K | 124.2K |